ATI Physical Therapy, Inc.
ATIPDelisted Dec 4, 2024- Industry
- Services-Nursing & Personal Care Facilities
- SEC CIK
- 0001815849
ATI Physical Therapy, Inc. was delisted on Dec 4, 2024; its insiders filed their last Form 4 on May 14, 2025; 18 institutions reported holding it in 13F filings for Q3 2024, worth $18.3M in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 2:25 PM ET
Revenue flow, FY2024
Where the revenue went in FY2024, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2024: $58.3M (7.7% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Sep 30, 2020 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K/A |
| Reported | Jan 8, 2025 | Feb 26, 2024 | Mar 16, 2023 | Feb 25, 2022 | – |
| Revenue | $753.1M | $699.0M | $635.7M | $627.9M | – |
| Selling, general and administrative | $99.7M | $118.7M | $114.7M | $111.8M | – |
| Operating income | $2.28M | -$27.5M | -$539.7M | -$980.0M | – |
| Income tax | $1.45M | $2.57M | -$48.5M | -$71.0M | – |
| Net income | -$58.3M | -$69.8M | -$492.4M | -$778.3M | – |
| EPS, basic | $-19.46 | $-31.93 | $-2.51 | $-4.69 | – |
| EPS, diluted | $-19.46 | $-31.93 | $-2.51 | $-4.69 | – |
| Weighted shares, basic | 4.32M | 4.13M | 203.2M | 165.8M | – |
| Weighted shares, diluted | 4.32M | 4.13M | 203.2M | 165.8M | – |
| Margins and growth | |||||
| Operating margin | 0.3% | -3.9% | -84.9% | -156.1% | – |
| Net margin | -7.7% | -10.0% | -77.5% | -124.0% | – |
| Revenue growth, year over year | +7.7% | +10.0% | +1.2% | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2024! | FY2023! | FY2022! | FY2021 | FY2020! |
|---|---|---|---|---|---|
| Period end | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Sep 30, 2020 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K/A |
| Reported | Jan 8, 2025 | Feb 26, 2024 | Mar 16, 2023 | Feb 25, 2022 | – |
| Cash and equivalents | $39.1M | $36.8M | $83.1M | $48.6M | $1.47M |
| Accounts receivable | $102.0M | $88.5M | $80.7M | $82.5M | – |
| Total current assets | $157.9M | $168.6M | $194.1M | $143.6M | $1.94M |
| Property, plant and equipment | $81.5M | $100.4M | $123.7M | $139.7M | – |
| Goodwill | $289.6M | $289.6M | $286.5M | $608.8M | – |
| Intangible assets | $245.5M | $245.9M | $246.6M | $411.7M | – |
| Total assets | $958.1M | $1.00B | $1.08B | $1.56B | $347.0M |
| Accounts payable | $18.2M | $14.7M | $12.6M | $15.1M | – |
| Short-term debt | – | – | $0 | $8.17M | – |
| Total current liabilities | $141.2M | $156.4M | $116.5M | $137.3M | $1.61M |
| Long-term debt | – | – | $531.6M | $543.8M | – |
| Total liabilities | $883.3M | $878.7M | $890.2M | $1.05B | $42.9M |
| Shareholders' equity | -$171.4M | -$95.9M | $48.4M | $511.5M | $5.00M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Sep 30, 2020 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K/A |
| Reported | Jan 8, 2025 | Feb 26, 2024 | Mar 16, 2023 | Feb 25, 2022 | – |
| Operating cash flow | -$19.2M | -$12.4M | -$65.5M | -$42.1M | – |
| Capital expenditures | $14.8M | $17.3M | $28.1M | $40.3M | – |
| Free cash flow | -$34.0M | -$29.7M | -$93.7M | -$82.4M | – |
| Depreciation and amortization | $33.2M | $37.4M | $40.6M | $38.0M | – |
| Stock-based compensation | $9.67M | $8.77M | $7.37M | $5.75M | – |
| Investing cash flow | -$14.3M | -$17.4M | -$28.0M | -$39.9M | – |
| Financing cash flow | $35.7M | -$16.6M | $128.1M | -$11.5M | – |
| Net change in cash | $2.28M | -$46.3M | $34.5M | -$93.5M | – |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.3% | 1.3% | 1.2% | 0.9% | – |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Feb 28, 2025 | 4.41M | +4.8% | SEC |
| Oct 30, 2024 | 4.41M | +4.8% | SEC |
| Jul 31, 2024 | 4.40M | +4.6% | SEC |
| May 1, 2024 | 4.40M | −97.9% | SEC |
| Feb 19, 2024 | 4.21M | −98.0% | SEC |
| Nov 1, 2023 | 4.21M | −98.0% | SEC |
| Aug 2, 2023 | 4.21M | −98.0% | SEC |
| May 3, 2023 | 208.5M | +0.8% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits. Stock splits since Sep 30, 2019, from 13F share counts: 1-for-50 in Q2 2023.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.